Charlie Lees
3y ago
All of this happened in IBD this month 👇
🧵 thread featuring:
• VEGA pub
• UPFs & Crohn's
• ADA descalation
• pharma news items
• an amazing 5-ASA story
• serological signatures & CD
• IFX biosimilar multi-switching
• a brilliant new website of IBD trials
1/14
Charlie Lees
3y ago
The IBD-EII website
All clinical trials in IBD on a timeline and brilliantly summarise by @Bealoquebea
Dive in and explore for your self - over 150 studies!
2/14
Charlie Lees
3y ago
The VEGA study was published
Combination guselkumab plus golimumab versus monotherapy of each agent in moderate active UC
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00427-7/fulltext
3/14
Charlie Lees
3y ago
Increased dose interval versus conventional dosing of adalimumab in Crohn's disease - the Ladi Trial
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00434-4/fulltext
4/14
Charlie Lees
3y ago
Epidemiology of IBD in Denmark
Evidence of a peak in incidence?
https://journals.lww.com/ajg/Abstract/9900/Has_the_Incidence_of_Inflammatory_Bowel_Disease.652.aspx
5/14
Charlie Lees
3y ago
Microbial enzymes discovered that inactivate 5-ASA and predict clinical non-response
Amazing multi-omics study with should translate to true precision medicine for UC
6/14
Charlie Lees
3y ago
Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism
Intriguing study in mice suggests that daily administration of a specific probiotic could be beneficial
https://gut.bmj.com/content/early/2023/01/03/gutjnl-2021-326835
7/14
Charlie Lees
3y ago
Ultra-processed foods and the development of Crohn's disease
Further support of this association from a meta-analysis
https://www.cghjournal.org/article/S1542-3565(23)00071-X/fulltext#.Y95uzG2MWNY.twitter
8/14
Charlie Lees
3y ago
Multiple switching of infliximab biosimilars is safe and
effective in IBD
Our 3x switch data from Edinburgh IBD Unit should offer great reassurance here
9/14
Charlie Lees
3y ago
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis
Data from the GEM Study nested cohort
https://gut.bmj.com/content/early/2023/02/16/gutjnl-2022-328421
10/14
Charlie Lees
3y ago
Preclinical Serological Signatures are Associated with Complicated Crohn's Disease Phenotype at Diagnosis
Patients with complicated CD had higher levels of anti-microbial antibodies detected 6 years prior to diagnosis
https://www.cghjournal.org/article/S1542-3565(23)00100-3/pdf
11/14
Charlie Lees
3y ago
High perceived stress associated with disease flares in ulcerative colitis
https://www.cghjournal.org/article/S1542-3565(22)00721-2/fulltext
12/14
Charlie Lees
3y ago
Pharma news stories
https://twitter.com/charlie_lees/status/1623667554781736961?s=20
13/14
Charlie Lees
3y ago
Next week is the highlight of the year!
See you all in Copenhagen for ECCO.
Pop by and say hello, and if you arrive early you can let me know - i'm here already.
14/14